Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Net Margin
Rohto Pharmaceutical Co Ltd

9.7%
Current
11%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.7%
=
Net Income
27.3B
/
Revenue
282.1B

Net Margin Across Competitors

Country JP
Market Cap 640.7B JPY
Net Margin
10%
Country FR
Market Cap 176B EUR
Net Margin
15%
Country UK
Market Cap 117.3B GBP
Net Margin
11%
Country IN
Market Cap 5.7T INR
Net Margin
17%
Country UK
Market Cap 34.7B GBP
Net Margin
11%
Country DE
Market Cap 27.7B EUR
Net Margin
8%
Country US
Market Cap 25.1B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
5%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 909.1B INR
Net Margin
14%
Country US
Market Cap 10.2B USD
Net Margin
12%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.7%
=
Net Income
27.3B
/
Revenue
282.1B
What is the Net Margin of Rohto Pharmaceutical Co Ltd?

Based on Rohto Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 9.7%.